KIDS OrthoPediatrics Corp

OrthoPediatrics Corp. Introduces Orthex in Australia

OrthoPediatrics Corp. Introduces Orthex in Australia

WARSAW, Ind., Jan. 22, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, continues to expand their product offering in Australia and New Zealand. Within the past 12 months we have launched the Pediatric Nailing Platform (PNP), Response 4.5/5.0 Spine System and most recently, the Orthex system.

Orthex is an external fixation and hexapod system consisting of ring, struts, implants, hardware accessories, and novel Point & Click Software for deformity correction in both the upper and lower extremities. Orthex’s telescoping struts provide greater range, fewer strut changes, reduced inventory requirements and greater precision, while eliminating frame vibration. The patented Orthex Point & Click software is a user-friendly system which eliminates the need for the surgeon to measure any mounting parameters. Through the step-by-step Point & Click process, the user completes Center of Rotation of Angulation (“CORA”) deformity planning, and the software calculates the necessary angles and translations to align the bones and correct the deformity.

Dr. Leo Donnan, Chief of Surgery at the Royal Children’s Hospital and Clinical Associate Professor University of Melbourne, commented on his early experience with Orthex, “The hexapod frame has become an integral part of Limb Reconstructive Surgery, and the introduction of the Orthex device in an already crowded space has been an easy transition because the device is mature in its development. The company and its representatives are keen to listen, learn and react. Their hands-on training and support is excellent. There is no way to go but up from what I and my colleagues have experienced so far. We would expect this to become the premier device for reconstructive surgery as OrthoPediatrics works with surgeons to refine and develop the frame and its software.”

About OrthoPediatrics Corp.

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets 35 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and 43 countries outside the United States. For more information, please visit .

Investor Contact

The Ruth Group

Jan Medina, CFA

(646) 536-7035



EN
22/01/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OrthoPediatrics Corp

 PRESS RELEASE

OrthoPediatrics Corp. to Report Second Quarter Financial Results on Au...

OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025 WARSAW, Ind., July 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2025 financial results on August 5, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 5, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call...

 PRESS RELEASE

Global POISE Study Reaches Milestone of 600 Orthopedic Implants in Ped...

Global POISE Study Reaches Milestone of 600 Orthopedic Implants in Pediatric Patients, Advancing Research on the Safety and Efficacy of OrthoPediatrics® Products WARSAW, Ind., July 16, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced a significant milestone in the ongoing Global POISE (Pediatric Orthopedic Implant Safety and Efficacy) Study: more than 600 implants are now being observed across 300+ pediatric patients as part of this study. ...

 PRESS RELEASE

OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annu...

OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting Reinforced Long-Term Commitment as Emerald Sponsor WARSAW, Ind., May 14, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued support of the 2025 Pediatric Orthopaedic Society of North America (“POSNA”) annual meeting as an Emerald Sponsor. At the Annual Meeting, the Company will highlight its growing portfolio of pediatric-specific solutions, including...

 PRESS RELEASE

OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and...

OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance First Quarter 2025 Revenue Increased 17% Year-over-Year WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 and Business Highlights Helped a record of nearly 39,000 children in the first quarter of 2025Generated total revenue of...

 PRESS RELEASE

OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ ...

OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ Pediatric Plating Platform™ Hip System WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its Trauma and Deformity portfolio with 3P™ Pediatric Plating Platform™ Hip System, the first of several systems in the 3P family. This represents the company’s 5th FDA approval in 2025. 3P Pediatric Plating Platform Hip System is a new plate and scre...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch